SEC Form 4 · accession 0000899243-17-008372
Pulmatrix, Inc. · PULM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W. Clarke
Officer — Chief Executive Officer · Director
Period of report
Mar 20, 2017
Accepted (ET)
Mar 22, 2017 · 3:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001574235
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 22, 2017 | M | 4,525 | $2.21 | A | 4,525 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.78 | Mar 20, 2017 | A | 159,000 | A | — | Mar 20, 2027 | Common Stock | 159,000 | 159,000 | D |
| Stock Option (Right to Buy)F3,F2 | $2.21 | Mar 22, 2017 | M | 4,525 | D | — | Feb 10, 2020 | Common Stock | 4,525 | 2,665 | D |
Explanation of responses
- F1The option vests as to 25% on March 20, 2018 and the remaining 75% vests in thirty-six (36) equal monthly installments with 2.083% vesting for each of the next thirty-six (36) months that follow March 20, 2018, subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.
- F2The option, representing the right to purchase a total of 7,190 shares of common stock, was fully vested and exercisable as of February 10, 2014.
- F3On March 22, 2017, the Reporting Person acquired 4,525 shares of common stock upon a partial exercise of this option. Following the exercise, the Reporting Person may acquire an additional 2,665 shares of common stock pursuant to this option.